Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Behestan Daru is a leading Iranian pharmaceutical company established in 2001, primarily focused on the importation, distribution, and local manufacturing of high-quality medicinal products. As a key subsidiary of the Behestan Group, the company represents numerous global pharmaceutical giants, including Roche, Novartis, and Sanofi, bringing advanced therapies to the Iranian market. Their portfolio spans a wide range of therapeutic areas such as oncology, hematology, transplantation, and rare diseases. In addition to its commercial activities, Behestan Daru has expanded into local production through its manufacturing arm, Behestan Tolid, ensuring the availability of essential medicines. The company is recognized for its commitment to international quality standards and its role in improving healthcare access within the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Behestan Daru.